Molecular and Therapeutic Potential and Toxicity of Yalproic AcidCHATEAUVIEUX, Sébastien; MORCEAU, Franck; DICATO, Mario et al.Journal of Biomedicine and Biotechnology (Print). 2010, Vol 2010, issn 1110-7243, 479364.1-479364.18, 3Article

Tumor necrosis factor alpha-mediated inhibition of erythropoiesis involves GATA-1/GATA-2 balance impairment and PU.1 over-expressionGRIGORAKAKI, Christine; MORCEAU, Franck; CHATEAUVIEUX, Sébastien et al.Biochemical pharmacology. 2011, Vol 82, Num 2, pp 156-166, issn 0006-2952, 11 p.Article

Linking anemia to inflammation and cancer : The crucial role of TNFaBUCK, Isabelle; MORCEAU, Franck; GRIGORAKAKI, Christina et al.Biochemical pharmacology. 2009, Vol 77, Num 10, pp 1572-1579, issn 0006-2952, 8 p.Article

Increased glutathione S-transferase P1-1 expression by mRNA stabilization in hemin-induced differentiation of K562 cellsSCHNEKENBURGER, Michael; MORCEAU, Franck; DUVOIX, Annelyse et al.Biochemical pharmacology. 2004, Vol 68, Num 6, pp 1269-1277, issn 0006-2952, 9 p.Article

Inhibition of TNFα-induced activation of nuclear factor κB by kava (Piper methysticum) derivativesFOLMER, Florence; BLASIUS, Romain; MORCEAU, Franck et al.Biochemical pharmacology. 2006, Vol 71, Num 8, pp 1206-1218, issn 0006-2952, 13 p.Article

Phorbol ester responsiveness of the glutathione S-transferase P1 gene promoter involves an inducible c-jun binding in human K562 leukemia cellsBORDE-CHICHE, Patricia; DIEDERICH, Marc; MORCEAU, Franck et al.Leukemia research. 2001, Vol 25, Num 3, pp 241-247, issn 0145-2126Article

Regulation of transcription of the glutathione S-transferase P1 gene by methylation of the minimal promoter in human leukemia cellsBORDE-CHICHE, Patricia; DIEDERICH, Marc; MORCEAU, Franck et al.Biochemical pharmacology. 2001, Vol 61, Num 5, pp 605-612, issn 0006-2952Article

The inhibitory effect of the proinflammatory cytokine TNFa on erythroid differentiation involves erythroid transcription factor modulationBUCK, Isabelle; MORCEAU, Franck; CRISTOFANON, Silvia et al.International journal of oncology. 2009, Vol 34, Num 3, pp 853-860, issn 1019-6439, 8 p.Article

Regulation of glutathione S-transferase P1-1 gene expression by NF-kappaB in tumor necrosis factor alpha-treated K562 leukemia cellsMORCEAU, Franck; DUVOIX, Annelyse; DELHALLE, Sylvie et al.Biochemical pharmacology. 2004, Vol 67, Num 7, pp 1227-1238, issn 0006-2952, 12 p.Article

Valproic acid perturbs hematopoietic homeostasis by inhibition of erythroid differentiation and activation of the myelo-monocytic pathwayCHATEAUVIEUX, Sébastien; EIFES, Serge; MORCEAU, Franck et al.Biochemical pharmacology. 2011, Vol 81, Num 4, pp 498-509, issn 0006-2952, 12 p.Article

Heteronemin, a spongean sesterterpene, inhibits TNFα-induced NF-_KB activation through proteasome inhibition and induces apoptotic cell deathSCHUMACHER, Marc; CERELLA, Claudia; EIFES, Serge et al.Biochemical pharmacology. 2010, Vol 79, Num 4, pp 610-622, issn 0006-2952, 13 p.Article

Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibitionDUVOIX, Annelyse; MORCEAU, Franck; DELHALLE, Sylvie et al.Biochemical pharmacology. 2003, Vol 66, Num 8, pp 1475-1483, issn 0006-2952, 9 p.Conference Paper

Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibitionDUVOIX, Annelyse; DELHALLE, Sylvie; BLASIUS, Romain et al.Biochemical pharmacology. 2004, Vol 68, Num 6, pp 1101-1111, issn 0006-2952, 11 p.Article

UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cellsJUNCKER, Tom; CERELLA, Claudia; DIEDERICH, Marc et al.Biochemical pharmacology. 2011, Vol 81, Num 1, pp 13-23, issn 0006-2952, 11 p.Article

Tumor necrosis factor a inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulationBUCK, Isabelle; MORCEAU, Franck; CRISTOFANON, Silvia et al.Biochemical pharmacology. 2008, Vol 76, Num 10, pp 1229-1239, issn 0006-2952, 11 p.Article